683a162ec782e11e38d1b250
10070
ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC)
ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC)
ALBI Grade for HCC
Predicts survival in HCC patients.
HCC survival.
albi-albumin-bilirubin-grade-hepatocellular-carcinoma-hcc
The ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC) predicts survival in HCC patients.
Albumin, bilirubin, liver function, liver dysfunction, HCC survival, C-P grade, Child-Pugh grade
[ "Abdominal Pain", "Jaundice" ]
ALBI = (log10bilirubin × 0.66) + (albumin × -0.085), where bilirubin is in μmol/L and albumin in g/L.
[ { "name": "Bilirubin", "unit": "bili", "error_min": "1E-8", "error_max": "50", "warn_min": "0", "warn_max": "20", "conversion": "17.104", "normal_max_si": "32.49", "normal_max_us": "1.9", "normal_min_si": "5.13", "normal_min_us": "0.3", "units_si": "µmol/L", "units_us": "mg/dL" }, { "name": "Albumin (General)", "unit": "alb", "error_min": "0", "error_max": "7", "warn_min": "1", "warn_max": "6", "conversion": "10", "normal_max_si": "55", "normal_max_us": "5.5", "normal_min_si": "35", "normal_min_us": "3.5", "units_si": "g/L", "units_us": "g/dL" } ]
Interpretation:
|
ALBI Score |
Grade |
Median survival |
|
≤-2.60 |
1 |
18.5-85.6 months |
|
>-2.60 to ≤-1.39 |
2 |
5.3-46.5 months |
|
>-1.39 |
3 |
2.3-15.5 months |
{ "Clinical Practice Guidelines": [ { "href": "", "text": "" } ], "Manufacturer Website": [ { "href": "", "text": "" } ], "Original/Primary Reference": [ { "href": "https://www.ncbi.nlm.nih.gov/pubmed/25512453", "text": "Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550-8." } ], "Other References": [ { "href": "https://www.ncbi.nlm.nih.gov/pubmed/28626732", "text": "Hiraoka A, Kumada T, Kudo M, et al. Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications. Liver Cancer. 2017;6(3):204-215." } ], "Outcomes": [ { "href": "", "text": "" } ], "Validation": [ { "href": "https://www.ncbi.nlm.nih.gov/pubmed/29234636 ", "text": "Hiraoka A, Michitaka K, Kumada T, et al. Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function. Liver Cancer. 2017;6(4):325-336." }, { "href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478326/", "text": "Chen B, Lin S. Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure. Medicine (Baltimore). 2017;96(24):e7142." }, { "href": "https://onlinelibrary.wiley.com/doi/full/10.1111/liv.13527", "text": "Lee PC, Chen YT, Chao Y, et al. Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinoma. Liver Int. 2018;38(2):321-330." } ], "Validations": [] }
Use in patients with hepatocellular carcinoma (HCC) to assess liver function and prognosis.
Provides an objective, validated measure of liver function based solely on albumin and bilirubin levels. Correlates with overall survival, making it useful for staging and prognostic assessments in HCC. Non-invasive and simple to calculate. Offers an alternative to theChild-Pugh Scorethat excludes subjective elements (e.g., encephalopathy).
[ "Hepatocellular Carcinoma" ]
{ "conditionality": "", "default": null, "fhir_rules": null, "inct": null, "label_en": "Bilirubin", "name": "bilirubin", "optional": false, "tips_en": "", "type": "textbox", "unit": "bili" }
{ "conditionality": "", "default": null, "fhir_rules": null, "inct": null, "label_en": "Albumin", "name": "albumin", "optional": false, "tips_en": "", "type": "textbox", "unit": "alb" }
[ { "conditionality": "", "default": null, "fhir_rules": null, "inct": null, "label_en": "Bilirubin", "name": "bilirubin", "optional": false, "tips_en": "", "type": "textbox", "unit": "bili" }, { "conditionality": "", "default": null, "fhir_rules": null, "inct": null, "label_en": "Albumin", "name": "albumin", "optional": false, "tips_en": "", "type": "textbox", "unit": "alb" } ]
2022-04-21T20:28:13.780Z
[ "Prognosis" ]
[ "Albi score" ]
{ "keywords_en": "Albumin, bilirubin, liver function, liver dysfunction, HCC survival, C-P grade, Child-Pugh grade", "meta_description_en": "The ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC) predicts survival in HCC patients." }
[ "Gastroenterology", "Hematology and Oncology", "Hepatology", "Hospitalist Medicine", "Internal Medicine" ]
[ "Gastrointestinal", "Oncologic" ]
[]
1
[]
[ { "calcId": 340, "short_title_en": "Child-Pugh Score", "slug": "child-pugh-score-cirrhosis-mortality" }, { "calcId": 10147, "short_title_en": "UKELD Score", "slug": "united-kingdom-model-end-stage-liver-disease-ukeld" }, { "calcId": 10240, "short_title_en": "CLIF-C ACLF", "slug": "clif-c-aclf-acute-chronic-liver-failure" } ]
false
[ "whenToUseViewed", "pearlsPitfallsViewed", "whyUseViewed", "nextStepsViewed", "evidenceViewed" ]
[ "gastroenterology", "oncology" ]
[ "Use in patients with hepatocellular carcinoma (HCC) to assess liver function and prognosis." ]
false